Sign up to save your podcasts
Or
Share Big Week Ahead For Stocks… And Emergent’s Mpox Approval 8/30/24
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Big Week Ahead For Stocks… And Emergent’s Mpox Approval 8/30/24
August trading is in the books, and after a rough start to the month, stocks managed to rebound. But with a big week on deck, can the bounce back continue? Plus Biotech company Emergent Bio getting FDA approval for its smallpox vaccine to treat mpox. What it could mean for Emergent’s future and the space as a whole.
Fast Money Disclaimer
View all episodes
By CNBC
3.9
12371,237 ratings
August trading is in the books, and after a rough start to the month, stocks managed to rebound. But with a big week on deck, can the bounce back continue? Plus Biotech company Emergent Bio getting FDA approval for its smallpox vaccine to treat mpox. What it could mean for Emergent’s future and the space as a whole.
Fast Money Disclaimer
More shows like CNBC's "Fast Money"
View all
Mad Money w/ Jim Cramer
4,081 Listeners
Investing Insights
495 Listeners
CNBC's "Options Action"
238 Listeners
Motley Fool Money
3,179 Listeners
Your Money Minute
147 Listeners
The Exchange
327 Listeners
Fortt Knox
67 Listeners
Strange Success with Jane Wells
153 Listeners
American Greed Podcast
2,125 Listeners
The Compound and Friends
2,073 Listeners
Squawk on the Street
600 Listeners
Squawk Pod
544 Listeners
The Keynote by CNBC Events
20 Listeners
Barron's Live
200 Listeners
Halftime Report
407 Listeners
CNBC's "Last Call"
302 Listeners
Worldwide Exchange
115 Listeners
RiskReversal Pod
807 Listeners
MRKT Matrix
180 Listeners
TechCheck
60 Listeners
Closing Bell
156 Listeners
Power Lunch
22 Listeners
Manifest Space with Morgan Brennan
34 Listeners
CNBC’s “Money Movers”
16 Listeners
CNBC Business News Update
9 Listeners
The Crimes of Putin’s Trader
261 Listeners
CNBC Sport
15 Listeners